Join
Live feed
·
INSIDERFilingvia Quantisnow
LB Pharmaceuticals Inc logo

Director Nussbaum Ran converted options into 411,681 shares and bought $15,000,000 worth of shares (1,000,000 units at $15.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LBRX· LB Pharmaceuticals Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LBRX (LB Pharmaceuticals Inc) and more on Quantisnow.